Curis Inc. (CRIS) stock Bullish Pre-Market on Data from its Clinical Trials
Gule Rukhsar
January 7, 2022
On January 06, Curis Inc. (CRIS) announced updated data from Phase ½ Study of CA-4948 and initial clinical data from Phase 1 Study of CI-8993.